In fiscal year 2024, GlaxoSmithKline Pharmaceuticals Limited in India reported around nine billion Indian rupees as earnings before interest, tax, depreciation and amortization. This was an increase compared to the previous fiscal year's eight billion rupees worth EBITDA. In financial year 2024, GSK ranked as the leading brand in the private vaccine market and dermatology segment.
EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2024
(in billion Indian rupees)
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
Print the statistic including description and metadata.
Chart type
EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2024
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
GlaxoSmithKline. (June 5, 2024). EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2024 (in billion Indian rupees) [Graph]. In Statista. Retrieved February 23, 2025, from https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. "EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2024 (in billion Indian rupees)." Chart. June 5, 2024. Statista. Accessed February 23, 2025. https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. (2024). EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2024 (in billion Indian rupees). Statista. Statista Inc.. Accessed: February 23, 2025. https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline. "Ebitda of Gsk Pharmaceuticals Limited in India from Financial Year 2015 to 2024 (in Billion Indian Rupees)." Statista, Statista Inc., 5 Jun 2024, https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
GlaxoSmithKline, EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2024 (in billion Indian rupees) Statista, https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/ (last visited February 23, 2025)
EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2024 (in billion Indian rupees) [Graph], GlaxoSmithKline, June 5, 2024. [Online]. Available: https://www.statista.com/statistics/992894/india-ebitda-gsk-pharmaceuticals/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.